Clinical Trial

Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction

Study acronym: TSTENT
Recruiting
View on ClinicalTrials.gov →
Summary
Malignant ureteral obstruction (MUO) is an extrinsic ureteral obstruction caused by malignant diseases. This study aim to compare tandem 6 Fr Percuflex™ stents and single large-caliber 8Fr silicone stent in patients with MUO. The primary endpoint is stent failure rate. The secondary endpoints are patient comfort, quality of life and overall survival.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-08-08.
Status change: Not Yet Recruiting → Recruiting 2025-07-22
Trial Details
NCT Number NCT05992363
Lead Sponsor Rabin Medical Center
Collaborators: Sheba Medical Center
Conditions Hydronephrosis; Obstruction, Ureter, Renal Failure, Malignancy, Ureter Obstruction, Ureter Stricture
Enrollment 106 participants
Start Date 2023-12-20
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-07-24